WANG Jin-wei,ZHANG Li,GU Yi-cun,et al.Changes of serum inhibin B levels in different perimenopausal stages and its clinical significance[J].Journal of Tongji University(Medical Science),2014,35(2):94-97. [点击复制]
Changes of serum inhibin B levels in different perimenopausal stages and its clinical significance
WANG Jin-wei1,ZHANG Li1,GU Yi-cun1,YANG Wen-wei2,SHI Yun-xing3
(1. Dept. of Gynecology and Obstetrics, Central Hospital of Huangpu District, Shanghai 200002, China;2. Dept. of Clinical Laboratory, Central Hospital of Huangpu District, Shanghai 200002, China;3. Dept. of Internal Medicine, No 411 Hospital of PLA, Shanghai 200081,China)
Abstract:
Objective To investigate changes of serum inhibin B (INHB ) levels in different perimenopausal stages and its clinical significance. Methods One hundred and eighteen women aged 45?53,who visited gynecology clinic for consultation or health check from March 2010 to July 2012, were enrolled in the study. All subjects were divided into four groups according to the menstrual cycle:control group (n=30) with regular menstrual cycles,early perimenopausal group (n=30),late perimenopausal group(n=28) and postmenopausal group(n=30). Serum inhibin(INHB) levels were detected by enzyme-linked immunosorbent assay ( ELISA);serum estradiol ( E2) and follicle-stimulating hormone ( FSH) levels were detected by radioimmunoassay. Results Compared to controls, INHB levels in early perimenopause were decreased(t=2.79,P<0.01),but no significant changes in serum FSH and E2(P>0.05). A significant increase in FSH (t=1.61, P<0.001) and decline in E2(r=6.43, P<0.001) were detected in late perimenopause, while INHB presented a tendency of decline but not significantly. Compared to late perimenopause, INHB levels in postmenopause were declined(r=2.68, P<0.01), FSH further increased(t=3.41,P<0.01) and E2 further declined (t=3.39, P<0.01). The INHB changes were negatively correlated with FSH levels(r=-0.423,P<0.01) and positively correlated with E2 levels (r=0.407,P<0.01). Conclusion Serum INRB level in perimenopausal women may be used as a biochemical marker for predicting ovarian failure and menopause.